Associated Papers
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.
Tangermann C et al.
Nature Genetics, 2026
41361008 (PubMed )
Supplement: 41588_2025_2431_MOESM5_ESM.xlsx › Figure_1d
Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors.
Boni J et al.
The Embo Journal, 2025
41174249 (PubMed )
Supplement: 44318_2025_600_MOESM1_ESM.pdf
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.
Apfelbaum AA et al.
Nature Communications, 2025
Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas.
Tang R et al.
Frontiers in Oncology, 2025
Patient with Diffuse Midline Glioma, H3 K27-altered, Carrying an FGFR1 Mutation Who Experienced Thalamic Hemorrhage: A Case Report and Literature Review.
Matsunaga K et al.
Nmc Case Report Journal, 2023
Identification of pathogenic missense mutations using protein stability predictors.
Gerasimavicius L et al.
Scientific Reports, 2020
32958805 (PubMed )
Supplement: 41598_2020_72404_MOESM2_ESM.xlsx › ClinVar
Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas.
Valera ET et al.
Acta Neuropathologica, 2018
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
Rivera B et al.
Acta Neuropathologica, 2016
Nuclear magnetic resonance analysis of the conformational state of cancer mutant of fibroblast growth factor receptor 1 tyrosine kinase domain.
Kobashigawa Y et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2016
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
Jones DT et al.
Nature Genetics, 2013
Select a paper to view details